Dupixent wins EU label expansion in COPD ahead of delayed FDA decision

Sanofi and Regeneron’s Dupixent has notched another indication in the EU, this time for a common lung disease, marking the first-ever targeted therapy for the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Kinarus Therapeutics Announces Personnel Changes – Biotech Investments

Kinarus Therapeutics Holding AG / Key word(s): Personnel Kinarus Therapeutics Announces Personnel Changes 12.07.2023 / 07:00 CET/CEST MEDIA RELEASE Basel, Switzerland, July 12, 2023 –

July 13, 2023

Bayer’s projects with Twist, Evotec; AbbVie buys out Parkinson’s drugmaker; A new drug discovery nonprofit in Toronto

Bayer teams up with Twist: The German drugmaker entered into a drug discovery deal with California biotech Twist Bioscience. Twist will use its synthetic antibody

October 6, 2023

Cassava Sciences and former execs, facing SEC charges for misleading claims, agree to fines

Facing charges from the Securities and Exchange Commission for misleading claims related to a controversial Alzheimer’s drug candidate, Cassava Sciences and two of the company’s

September 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.